Sophia Genetics reported Q2 revenue growth alongside a new AstraZeneca collaboration covering companion diagnostics in both solid and hematologic cancers. Sophia said the pact will support development, validation, and commercialization of two tests, leveraging its decentralized network and AI capabilities, with an expectation that the partnership will start boosting growth next year.